Welcome to LookChem.com Sign In|Join Free
  • or
4-(dimethylaminocarbonyl)trifluoromethoxybenzene is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

57330-50-4

Post Buying Request

57330-50-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

57330-50-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 57330-50-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,3,3 and 0 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 57330-50:
(7*5)+(6*7)+(5*3)+(4*3)+(3*0)+(2*5)+(1*0)=114
114 % 10 = 4
So 57330-50-4 is a valid CAS Registry Number.

57330-50-4Relevant academic research and scientific papers

Sequential Xanthalation and O-Trifluoromethylation of Phenols: A Procedure for the Synthesis of Aryl Trifluoromethyl Ethers

Yoritate, Makoto,Londregan, Allyn T.,Lian, Yajing,Hartwig, John F.

, p. 15767 - 15776 (2019/12/04)

Molecules containing trifluoromethoxyaryl groups are of interest in pharmaceutical, agrochemical, and materials science research, due to their unique physical and electronic properties. Many of the known methods to synthesize aryl trifluoromethyl ethers require harsh reagents and highly controlled reaction conditions and rarely occur when heteroaromatic units are present. The two-step O-trifluoromethylation of phenols via aryl xanthates is one such method that suffers from these drawbacks. Herein, we report a method for the synthesis of aryl trifluoromethyl ethers from phenols by the facile conversion of the phenol to the corresponding aryl and heteroaryl xanthates with newly synthesized imidazolium methylthiocarbonothioyl salts and conversion of these xanthates to the trifluoromethyl ethers under mild reaction conditions.

Visible-Light Photoredox-Catalyzed and Copper-Promoted Trifluoromethoxylation of Arenediazonium Tetrafluoroborates

Yang, Shaoqiang,Chen, Miao,Tang, Pingping

supporting information, p. 7840 - 7844 (2019/05/15)

We report the development of photoredox-catalyzed and copper-promoted trifluoromethoxylation of arenediazonium tetrafluoroborates, with trifluoromethyl arylsulfonate (TFMS) as the trifluoromethoxylation reagent. This new method takes advantage of visible-light photoredox catalysis to generate the aryl radical under mild conditions, combined with copper-promoted selective trifluoromethoxylation. The reaction is scalable, tolerates a wide range of functional groups, and proceeds regioselectively under mild reaction conditions. Furthermore, mechanistic studies suggested that a Cs[Cu(OCF3)2] intermediate might be generated during the reaction.

Oxidative amidation of benzaldehydes and benzylamines with: N -substituted formamides over a Co/Al hydrotalcite-derived catalyst

Gupta, Shyam Sunder R.,Nakhate, Akhil V.,Rasal, Kalidas B.,Deshmukh, Gunjan P.,Mannepalli, Lakshmi Kantam

, p. 15268 - 15276 (2017/12/15)

The present work describes a highly efficient synthetic strategy for amides via oxidative coupling of benzaldehydes or benzylamines with N-substituted formamides using a heterogeneous Co/Al hydrotalcite-derived catalyst in the presence of TBHP. A series of Co/Al hydrotalcite-derived catalysts (Cat-2, Cat-3, and Cat-4 with the Co2+/Al3+ molar ratio in the synthesis mixture as 1/1, 2/1 and 3/1) have been prepared by a simple co-precipitation method and characterized using powder XRD, XPS, FEG-SEM, EDS, FT-IR, DTG-TGA and N2 physical adsorption techniques. Among the as-prepared catalysts, Cat-3 exhibited excellent catalytic activity towards the direct amidation of benzaldehydes as well as benzylamines bearing various substituents into the corresponding amides at 100 °C using TBHP as an oxidant. The mechanistic investigation of the amidation reaction revealed that the reaction follows a radical pathway. Furthermore, the catalyst is easily separable and recyclable without considerable loss in catalytic activity.

Benzamide derivatives, preparation method of benzamide derivatives and application of benzamide derivatives in medicines

-

Paragraph 0150; 0151; 0152; 0153, (2017/11/18)

The invention relates to benzamide derivatives, a preparation method of benzamide derivatives and an application of the benzamide derivatives in medicines. Specifically, the invention relates to a benzamide derivative shown as a general formula (I), a preparation method of the benzamide derivative, medicinal salts thereof, as well as an application of the benzamide derivatives as therapeutic agents, particularly as glucagon receptor antagonists. The definition of each substituent group in the general formula (I) is the same as the definition in the specification.

Fluorodecarboxylation for the Synthesis of Trifluoromethyl Aryl Ethers

Zhang, Qing-Wei,Brusoe, Andrew T.,Mascitti, Vincent,Hesp, Kevin D.,Blakemore, David C.,Kohrt, Jeffrey T.,Hartwig, John F.

supporting information, p. 9758 - 9762 (2016/08/10)

The synthesis of mono-, di-, and trifluoromethyl aryl ethers by fluorodecarboxylation of the corresponding carboxylic acids is reported. AgF2induces decarboxylation of aryloxydifluoroacetic acids, and AgF, either generated in situ or added separately, serves as a source of fluorine to generate the fluorodecarboxylation products. The addition of 2,6-difluoropyridine increased the reactivity of AgF2, thereby increasing the range of functional groups and electronic properties of the aryl groups that are tolerated. The reaction conditions used for the formation of trifluoromethyl aryl ethers also served to form difluoromethyl and monofluoromethyl aryl ethers.

NEW CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF

-

Page/Page column 78, (2012/01/14)

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.

NEW SELECTIVE CCR2 ANTAGONISTS

-

Page/Page column 83-84, (2013/02/28)

The present invention relates to novel and selective antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD as well as pain.

CCR2 RECEPTOR ANTAGONISTS

-

Page/Page column 88, (2011/12/14)

The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 57330-50-4